Cargando…
The use of Low Molecular Weight Heparin to Predict Clinical Outcome in Patients with Unstable Angina That Had Undergone Percutaneous Coronary Intervention
BACKGROUND: Antithrombotic therapy with heparin reduces the rate of ischemic events in patients with acute coronary syndrome. Low-molecular-weight heparin, given subcutaneously twice daily, has a more predictable anticoagulant effect than standard unfractionated heparin. Moreover, it is easier to ad...
Autores principales: | Hong, Young Joon, Jeong, Myung Ho, Lee, Seung Hyun, Park, Ok Young, Kim, Ju Han, Kim, Weon, Rhew, Jay Young, Ahn, Young Keun, Cho, Jeong Gwan, Park, Jong Chun, Suh, Soon Pal, Ahn, Byoung Hee, Kim, Sang Hyung, Kang, Jung Chaee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531631/ https://www.ncbi.nlm.nih.gov/pubmed/14619386 http://dx.doi.org/10.3904/kjim.2003.18.3.167 |
Ejemplares similares
-
The Role of C-Reactive Protein on the Long-Term Clinical Outcome after Primary or Rescue Percutaneous Coronary Intervention
por: Hong, Young Joon, et al.
Publicado: (2003) -
Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro(®)), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention
por: Sim, Doo Sun, et al.
Publicado: (2003) -
An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention
por: Jeong, Woo Kon, et al.
Publicado: (2003) -
A Novel Method of Brachytherapy Using Local Delivery of (99m)Tc–HMPAO for Coronary Stent Restenosis
por: Kim, Weon, et al.
Publicado: (2004) -
Long-term Predictive Factors of Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Bae, Eun Hui, et al.
Publicado: (2005)